The International Classification of Headache Disorders
J. Olesen
|
12 |
2008 |
12
2008
|
Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
R. Lipton,
W. Stewart,
S. Diamond,
M. Diamond,
M. Reed
|
11 |
2001 |
11
2001
|
The CARE Guidelines: Consensus‐Based Clinical Case Reporting Guideline Development
J. Gagnier,
G. Kienle,
D. Altman,
D. Moher,
H. Sox,
David Riley
|
9 |
2013 |
9
2013
|
OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program
8 auth.
D. Dodick,
C. Turkel,
R. Degryse,
S. Aurora,
S. Silberstein,
R. Lipton,
...
H. Diener,
M. Brin
|
9 |
2010 |
9
2010
|
Migraine Diagnosis and Treatment: Results From the American Migraine Study II
R. Lipton,
S. Diamond,
M. Reed,
M. Diamond,
W. Stewart
|
9 |
2001 |
9
2001
|
Epidemiology of Chronic Daily Headache in the General Population
J. Castillo,
P. Muñoz,
V. Guitera,
J. Pascual
|
9 |
1999 |
9
1999
|
Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population‐Based Study
M. Bigal,
D. Serrano,
D. Buse,
A. Scher,
W. Stewart,
R. Lipton
|
9 |
2008 |
9
2008
|
Periaqueductal Gray Matter Dysfunction in Migraine: Cause or the Burden of Illness?
K. Welch,
V. Nagesh,
S. Aurora,
N. Gelman
|
9 |
2001 |
9
2001
|
Prevalence of Frequent Headache in a Population Sample
A. Scher,
W. Stewart,
J. Liberman,
R. Lipton
|
9 |
1998 |
9
1998
|
Regulation of Calcitonin Gene‐Related Peptide Secretion From Trigeminal Nerve Cells by Botulinum Toxin Type A: Implications for Migraine Therapy
P. Durham,
R. Cady,
R. Cady
|
9 |
2004 |
9
2004
|
The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies
M. Marmura,
S. Silberstein,
T. Schwedt
|
8 |
2015 |
8
2015
|
Cervicogenic Headache: Diagnostic Criteria
O. Sjaastad,
Fredriksen Ta,
Pfaffenrath
|
8 |
1998 |
8
1998
|
The Prevalence and Burden of Migraine and Severe Headache in the United States: Updated Statistics From Government Health Surveillance Studies
R. Burch,
Stephen Loder,
E. Loder,
T. Smitherman
|
8 |
2015 |
8
2015
|
Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study
7 auth.
D. Buse,
Aubrey N. Manack,
K. Fanning,
D. Serrano,
M. Reed,
C. Turkel,
...
R. Lipton
|
8 |
2012 |
8
2012
|
Classification of Daily and Near‐Daily Headaches: Proposed Revisions to the IHS Criteria
S. Silberstein,
R. Lipton,
S. Solomon,
N. Mathew
|
8 |
1994 |
8
1994
|
Efficacy and Safety of Topiramate for the Treatment of Chronic Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Trial
13 auth.
S. Silberstein,
R. Lipton,
D. Dodick,
F. Freitag,
N. Ramadan,
N. Mathew,
J. Brandes,
M. Bigal,
J. Saper,
S. Ascher,
...
D. Jordan,
S. Greenberg,
J. Hulihan
|
8 |
2007 |
8
2007
|
The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice
|
8 |
2018 |
8
2018
|
